{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T09:48:32Z","timestamp":1782294512006,"version":"3.54.5"},"reference-count":34,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Cosmetic Dermatology"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Onychodystrophy includes diverse nail disorders that may impair function and quality of life. Because nails grow slowly, adjunctive therapies that promote nail growth are of increasing interest.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This review examines the evidence for minoxidil in nail growth and nail disorders and proposes a treatment algorithm for its adjunctive use in onychodystrophy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A structured search of PubMed and Google Scholar was conducted on December 10, 2025, using terms related to minoxidil and nails. Records were deduplicated, screened, and appraised by full\u2010text review using the Oxford Centre for Evidence\u2010Based Medicine 2009 levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A potential adjunctive treatment algorithm is proposed, emphasizing treatment of the underlying nail disorder first. Topical minoxidil (2% or 5% solution or foam, applied once or twice daily to the proximal nail fold) or low\u2010dose oral minoxidil (LDOM; 0.625\u20132.5\u2009mg\/day in females and 1.25\u20135\u2009mg\/day in males) may then be considered, with appropriate monitoring and discontinuation criteria. Safety data for topical use indicate predominantly local irritation, whereas LDOM has been associated with tachycardia, edema, and other systemic adverse effects. Minoxidil may support nail growth through KATP channel\u2010mediated vasodilation and growth factor signaling, with downstream activation of the Wnt\/\u03b2\u2010catenin pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Minoxidil shows potential as an adjunct to support nail growth, but nail\u2010disorder\u2013specific evidence remains limited. Controlled trials are needed to define efficacy, optimal regimens, and safety in onychodystrophy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jocd.70863","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:50:32Z","timestamp":1776664232000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Topical Minoxidil and Low\u2010Dose Oral Minoxidil in Onychodystrophy: A Proposed Treatment Algorithm"],"prefix":"10.1111","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8664-7723","authenticated-orcid":false,"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[{"name":"Mediprobe Research Inc.  London Ontario Canada"},{"name":"Division of Dermatology, Temerty Faculty of Medicine University of Toronto  Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0691-640X","authenticated-orcid":false,"given":"Mesbah","family":"Talukder","sequence":"additional","affiliation":[{"name":"School of Pharmacy BRAC University  Dhaka Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5913-9304","authenticated-orcid":false,"given":"Shari R.","family":"Lipner","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Weill Cornell Medicine  New York City New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,4,19]]},"reference":[{"key":"e_1_2_15_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.03.062"},{"key":"e_1_2_15_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2022.2044511"},{"key":"e_1_2_15_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03426.x"},{"key":"e_1_2_15_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2024.2314087"},{"key":"e_1_2_15_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16574"},{"key":"e_1_2_15_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2021.1945527"},{"key":"e_1_2_15_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.5743"},{"key":"e_1_2_15_9_1","doi-asserted-by":"publisher","DOI":"10.1159\/000531890"},{"key":"e_1_2_15_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13620"},{"key":"e_1_2_15_11_1","doi-asserted-by":"publisher","DOI":"10.70933\/2773-9465.1088"},{"key":"e_1_2_15_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14316"},{"key":"e_1_2_15_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19213"},{"key":"e_1_2_15_14_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S301197"},{"key":"e_1_2_15_15_1","doi-asserted-by":"publisher","DOI":"10.1159\/000546583"},{"key":"e_1_2_15_16_1","unstructured":"\u201cOxford centre for evidence\u2010based medicine: levels of evidence \u201daccessed December 04 2025 https:\/\/www.cebm.ox.ac.uk\/resources\/levels\u2010of\u2010evidence\/oxford\u2010centre\u2010for\u2010evidence\u2010based\u2010medicine\u2010levels\u2010of\u2010evidence\u2010march\u20102009."},{"key":"e_1_2_15_17_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2024.4791"},{"key":"e_1_2_15_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.16608"},{"key":"e_1_2_15_19_1","first-page":"46","article-title":"Minoxidil as a Treatment for Onychodystrophy: A Systematic Review","volume":"22","author":"Thiagarajan A. B.","year":"2025","journal-title":"Journal of the American Academy of Dermatology International"},{"key":"e_1_2_15_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2025.07.039"},{"key":"e_1_2_15_21_1","unstructured":"\u201cPfizer LONITEN\u2010minoxidil tablet \u201d."},{"key":"e_1_2_15_22_1","unstructured":"\u201cLoniten (minoxidil) tablets for oral use (FDA label) \u201d."},{"key":"e_1_2_15_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.02.054"},{"key":"e_1_2_15_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/ics.12142"},{"key":"e_1_2_15_25_1","doi-asserted-by":"publisher","DOI":"10.3109\/1061186X.2014.929138"},{"key":"e_1_2_15_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X231213149"},{"key":"e_1_2_15_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00877622"},{"key":"e_1_2_15_28_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02115.x"},{"issue":"8","key":"e_1_2_15_29_1","first-page":"939","article-title":"Treatment of Nail Psoriasis With TNF\u2010\u03b1 or IL12\/23 Inhibitors","volume":"11","author":"Jemec G. B.","year":"2012","journal-title":"Journal of Drugs in Dermatology: JDD"},{"key":"e_1_2_15_30_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.123482"},{"key":"e_1_2_15_31_1","unstructured":"\u201cRogaine package insert Minoxidil Foam 5% w\/w \u201d."},{"key":"e_1_2_15_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2022.2109567"},{"key":"e_1_2_15_33_1","unstructured":"\u201cWomen's Rogaine package insert Minoxidil 2% Minoxidil Topical Solution \u201d."},{"key":"e_1_2_15_34_1","unstructured":"Bethesda \u201cDrugs and Lactation Database (LactMed): Minoxidil \u201d30 January 2026 https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501032."},{"key":"e_1_2_15_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0594-4"}],"container-title":["Journal of Cosmetic Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jocd.70863","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jocd.70863","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jocd.70863","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T09:24:26Z","timestamp":1782293066000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jocd.70863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1111\/jocd.70863"],"URL":"https:\/\/doi.org\/10.1111\/jocd.70863","archive":["Portico"],"relation":{},"ISSN":["1473-2130","1473-2165"],"issn-type":[{"value":"1473-2130","type":"print"},{"value":"1473-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2026-03-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70863"}}